Related Experiment Video
Updated: Mar 28, 2026

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
A cancer cell-line titration series for evaluating somatic classification
Robert E Denroche1, Laura Mullen2, Lee Timms3
1Ontario Institute for Cancer Research, Toronto, ON, Canada. rob.denroche@oicr.on.ca.
This study introduces a new cell-line titration dataset to evaluate somatic variant calling pipelines for cancer genomics. The dataset helps assess the reliable detection of true somatic mutations at low allele frequencies, even with normal cell contamination.
Area of Science:
- Genomics
- Cancer Research
- Bioinformatics
Background:
- Accurate detection of somatic variants in tumor-normal sequencing is challenging due to normal cell contamination and tumor heterogeneity.
- Sub-clonal variants at low allele frequencies are difficult to identify reliably.
Purpose of the Study:
- To present a cell-line titration series dataset for evaluating somatic variant calling pipelines.
- To enable reliable calling of true somatic mutations at low allele frequencies.
Main Methods:
- Generated samples by mixing cell-line DNA with matched normal DNA at 8 ratios, creating known tumor cellularities.
- Performed exome sequencing at >300× depth on Illumina HiSeq.
- Processed data with multiple variant calling pipelines and validated >1500 somatic variant candidates using Ion Torrent PGM.
Main Results:
- The best performing pipelines maintained high precision across all tested cellularities.
- Estimated the number of true somatic variants missed as cellularity and coverage decreased.
Conclusions:
- The cell-line titration dataset and verification results effectively evaluated somatic variant calling pipelines.
- This dataset will be valuable for future development of somatic calling algorithms.
- Data is publicly available via the European Genome-phenome Archive (EGAS00001001016).
More Related Videos
10:38Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs
Published on: December 16, 2022
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014